Absolute Contraindications
|
Age > 70 years |
Severe pulmonary hypertension with PAS > 50 mm Hg, TPG > 15 mm Hg, PVR > 3 Wood Units irreversible with milrinone/levosimendan |
Severe lung disease (e.g., forced expiratory volume in one second; and forced vital capacity <50% of predicted value) or evidence of parenchymal lung disease) |
Multisystem disease with poor long-term survival |
Viral infection (hepatitis B, hepatitis C, and HIV) with organ damage and with detectable viral titles |
Severe local or systemic infection not caused by left ventricular assist device |
Active smokers/substance abuse |
History of cancer (multidisciplinary cardio-oncology team evaluation is recommended) |
Severe neurological deficit/significant psychiatric illness |
Relative contraindications
|
Diabetes mellitus with end-organ damage (e.g., nephropathy, neuropathy, proliferative retinopathy) or poorly controlled diabetes with glycosylated hemoglobin persistently >7.5% or 58 mmol/mol |
Irreversible renal dysfunction with an estimated glomerular filtration rate <40 mL/min/1.73 m2 if the patient is not a candidate for a combined heart-kidney transplant |
Irreversible liver dysfunction (e.g., cirrhosis) if the patient is not a candidate for a combined heart-liver transplant. |
Severe obesity (BMI > 35 kg/m2) |
Psychosocial factors (Inability to make a solid commitment to transplantation, Absence of adequate external psychosocial supports) |